Skip to main content
Presentation
SECUKINUMAB PROVIDES RAPID AND SUSTAINED REDUCTIONS IN DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF DATA FROM THE PHASE 3 RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED FUTURE 2 STUDY. Spanish Society of Rheumatology (SER), Bilbao, Spain, May 2017.
Spanish Society of Rheumatology (SER) (2017)
  • B Kirkham
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Disciplines
Publication Date
May, 2017
Citation Information
B Kirkham, Philip Mease and et.al.. "SECUKINUMAB PROVIDES RAPID AND SUSTAINED REDUCTIONS IN DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF DATA FROM THE PHASE 3 RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED FUTURE 2 STUDY. Spanish Society of Rheumatology (SER), Bilbao, Spain, May 2017." Spanish Society of Rheumatology (SER) (2017)
Available at: http://works.bepress.com/philip-mease/269/